InGeneron Alternatives & Competitors
12 companies similar to InGeneron — Unlocking Regenerative Cell Therapy
Companies similar to InGeneron
Lineage Cell Therapeutics
A clinical-stage biotechnology company developing novel cell therapies for unmet medical n...
Carlsbad, United States
Cell BioEngines, Inc
‘Off-the-Shelf’ Curative Cell Therapies
New York, United States
Notogen Inc.
Developing a disease-modifying regenerative therapy for degenerative disc disease
Toronto, Canada
Histocell. Regenerative Medicine
Advanced therapy medicinal products, medical devices and dermocosmetics for regenerative m...
Derio, Spain
Rival Readout
Competing with InGeneron? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
DiscGenics
REVOLUTIONIZING CARE FOR CHRONIC BACK PAIN
Salt Lake City, United St...
NeuroGenesis Bio Inc.
Cell Therapies for Neurodegenerative Diseases
Rochester, United States
Orchard Therapeutics - U.S.
Dedicated to transforming the lives of patients with severe and other genetic diseases thr...
London, United Kingdom
Celltex Therapeutics Corporation
A Houston-based biotech company focused on breakthroughs using autologous, adipose-derived...
Houston, United States
Aspen Neuroscience, Inc.
Developing autologous iPSC-derived cell replacement therapies for Parkinson’s disease and...
La Jolla, United States
Angiocrine Bioscience, Inc.
Transforming medicine through engineered cellular therapies that restore, regenerate, and...
San Diego, United States
APstem Therapeutics
An unprecedented era of stem cell therapy has arrived!
Fremont, United States
NOVADIP Biosciences S.A.
Novadip is transforming the lives of patients using its unique 3M³ tissue regeneration tec...
Belgium
About InGeneron
InGeneron is a clinical-stage biotechnology company that aims to revolutionize healthcare with its novel, safe, and evidence-based cell therapies. The company's mission revolves around unlocking the healing potential of each patient’s own regenerative cells processed at the point of care to enable same-day treatment, t...
Regenerative Cell Therapy, Clinical-stage Biotechnology, Orthopedic Conditions, Minimally Invasive Treatments, Cell Therapy Product Platform, Stem And Regenerative Cell Research, Autologous Adult Stem Cells, FDA-approved Therapies, Healthcare Innovation, Point-of-care Treatments
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around InGeneron: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at InGeneron on 14 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 11 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
